SCHEMBL30100702

SCHEMBL30100702

CC1(C)Cc2cc(Nc3cnc4ccc(C(=O)O)cc4n3)ccc2NC1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CASP3 P42574 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
JAK3 P52333 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
PDGFRB P09619 2/20 0.36
PDGFRA P16234 2/20 0.36
CRBN Q96SW2 1/20 0.36
PLK1 P53350 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
RHOA P61586 2/20 0.35
BRD4 O60885 1/20 0.35
IDH1 O75874 2/20 0.35
RARA P10276 1/20 0.34
RARB P10826 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30100761 0.91 CRBN (0.45) NPC1RAB9AMEN1ALDH1A1CASP3
SCHEMBL30100760 0.91 CRBN (0.45) NPC1RAB9AMEN1ALDH1A1CASP3
SCHEMBL23674970 0.91 CRBN (0.45) NPC1RAB9AMEN1ALDH1A1CASP3
SCHEMBL23674941 0.85 RHOA (0.47) NPC1RAB9AMEN1ALDH1A1CASP3
SCHEMBL26450785 0.78 CRBN (0.47) MEN1ALDH1A1KMT2ASMN1; SMN2CRBN
SCHEMBL26088757 0.77 BCL6 (0.43) MEN1KMT2AJAK3IRAK4CRBN
SCHEMBL30100704 0.74 KIF11 (0.35) PLK1KIF11
SCHEMBL26089499 0.74 KIF11 (0.35) PLK1KIF11
SCHEMBL26086897 0.73 RHOA (0.40) NPC1RAB9AMEN1ALDH1A1KMT2A
SCHEMBL26089307 0.73 KIF11 (0.34) IRAK4PLK1KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERSITY 2023-04-27 US disclosed
EP-4093400-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF The Trustees of Princeton University (US) 2022-11-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF PAH, ALDH2, IDH2 NPC1 2907/4885RAB9A 3407/4885MEN1 1551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.